About EVA Pharma 
EVA Pharma is dedicated to improving access to affordable, high-quality medicines around the world, focusing on three core pillars: innovation, development and sustainable access. The company leverages cutting-edge technology at two research centers bringing first-of-its-kind capabilities to the Middle East and Africa including mRNA research and development from AI prediction to biological products. &nbsp;
With a 5,000-strong team of professionals, EVA Pharma produces more than one million healthcare products a day at four state-of-the-art manufacturing facilities, which are internationally recognized for innovation, and have been approved by multiple regulatory agencies. &nbsp;
 Guided by a relentless drive to ensure sustainable access to pressing yet unmet disease areas, the company’s product portfolio focuses on twelve therapeutic areas: Anti-infectives, metabolic health, bone, neuroscience, oncology, respiratory, gynecology, urology and andrology, pediatrics, ophthalmology, gastrointestinal tract, family medicine to meet both local and international demand. &nbsp;
EVA Pharma is one of the fastest-growing healthcare companies in the Middle East and Africa, with an extensive pan-African presence, while operating in more than 60 countries worldwide. &nbsp;

thumbnail_Banner copy 2.png

Banner copy 2.png

CPHI Worldwide 2025 Frankfurt EVA Pharma is a global healthcare company operating across 70+ countries, dedicated

CPHI Worldwide 2025

thumbnail_header 1.jpg

header 1.jpg

Pharmaconex 2025 EVA Pharma is a global healthcare company operating across 70+ countries, dedicated

Pharmaconex 2025

About EVA Pharma 
EVA Pharma is a global healthcare company operating across 60+ countries, dedicated to addressing unmet patients’ needs through cutting-edge research &amp; innovation. The company boasts 2 research centers gathering first-of-its-kind capabilities to the Middle East and Africa including mRNA research and development from AI prediction to biological products.
In favor of its internationally accredited facilities and 5000+ professionals, EVA Pharma produces 1 million medicines daily, adhering to rigorous international standards.
Committed to bridging healthcare gaps globally, EVA Pharma expands its operations across the world, including Africa, particularly establishing key legal entities in Kenya and Nigeria and forging partnerships with key pharmaceutical companies. The company has a goal to enhance access to quality insulin for 30 million individuals annually living in limited-resource settings areas by 2030. Recently, it has worked to develop its vaccine- and API-manufacturing capacity, to bring essential novel healthcare technologies and products to Africa.

thumbnail_image (73).png

image (73).png

Africa Health ExCon 2025
EVA Pharma is a global healthcare company operating across 70+ countries, dedicated

Africa Health Excon 2025

&nbsp; &nbsp;

thumbnail_Booth-post_webTop-Banner 1.png

Booth-post_webTop-Banner 1.png

CPHI China 2025
EVA Pharma is a global healthcare company operating across 70+ countries, 

CPHI China 2025

Happening at EVA Pharma

EVA Pharma’s roots stretch back over a hundred years.

Our History

Our experienced leadership team keeps us on track.

Meet our Leaders

EVA Pharma’s success is based on its dynamic team, Our people are our power.

Life at EVA Pharma

EVA Pharma&nbsp;EVA Pharma is dedicated to improving access to affordable, high-quality medicines around the world, focusing on three core pillars: innovation, development and sustainable access. The company leverages cutting-edge technology at two research centers bringing first-of-its-kind capabilities to the Middle East and Africa including mRNA research and development from AI prediction to biological products. &nbsp;
With a 5,000-strong team of professionals, EVA Pharma produces more than one million healthcare products a day at four state-of-the-art manufacturing facilities, which are internationally recognized for innovation, and have been approved by multiple regulatory agencies. &nbsp;
 Guided by a relentless drive to ensure sustainable access to pressing yet unmet disease areas, the company’s product portfolio focuses on twelve therapeutic areas: Anti-infectives, metabolic health, bone, neuroscience, oncology, respiratory, gynecology, urology and andrology, pediatrics, ophthalmology, gastrointestinal tract, family medicine to meet both local and international demand. &nbsp;
EVA Pharma is one of the fastest-growing healthcare companies in the Middle East and Africa, with an extensive pan-African presence, while operating in more than 60 countries worldwide. &nbsp;

thumbnail_Footer copy 3.png

Footer copy 3.png

thumbnail_Screenshot 2025-06-17 112854.png

Screenshot 2025-06-17 112854.png

EVA Company Profile - Excon 2025 - Printing.pdf

Company Profile

thumbnail_CPHI25_webthum_SCMO.png

CPHI25_webthum_SCMO.png

CMO & CDMO milan Q3 2025.pdf

CMO & CDMO

thumbnail_Screenshot 2025-06-17 112622.png

Screenshot 2025-06-17 112622.png

MARC - EXCON 2025 Digital.pdf

Clinical Research 

thumbnail_Screenshot 2025-06-17 113128.png

Screenshot 2025-06-17 113128.png

EVA Pharma Product Portfolio 2025 Digital.pdf

Product Portfolio

thumbnail_CPHI25_webthum_Animal-Health-Portfolio.png

CPHI25_webthum_Animal-Health-Portfolio.png

Portfolio Animal health  1.pdf

Animal Health Portfolio

thumbnail_Screenshot 2025-06-17 111006.png

Screenshot 2025-06-17 111006.png

[20May] Interactive Brochure 2 (3).pdf

Limitless Naturals Portfolio

thumbnail_CPHI25_webthum_Supply-Chain.png

CPHI25_webthum_Supply-Chain.png

Curium 20x25. full.pdf

Supply Chain

Event

EVA Pharma is dedicated to improving access to affordable, high-quality medicines around the world, focusing on three core pillars: innovation, development and sustainable access. The company leverages cutting-edge technology at two research centers bringing first-of-its-kind capabilities to the Middle East and Africa including mRNA research and development from AI prediction to biological products. &nbsp;
With a 5,000-strong team of professionals, EVA Pharma produces more than one million healthcare products a day at four state-of-the-art manufacturing facilities, which are internationally recognized for innovation, and have been approved by multiple regulatory agencies. &nbsp;
 Guided by a relentless drive to ensure sustainable access to pressing yet unmet disease areas, the company’s product portfolio focuses on twelve therapeutic areas: Anti-infectives, metabolic health, bone, neuroscience, oncology, respiratory, gynecology, urology and andrology, pediatrics, ophthalmology, gastrointestinal tract, family medicine to meet both local and international demand. &nbsp;
EVA Pharma is one of the fastest-growing healthcare companies in the Middle East and Africa, with an extensive pan-African presence, while operating in more than 60 countries worldwide. &nbsp;

thumbnail_footer.jpg

footer.jpg

<h3>EVA Pharma's debut at CPHI China is set to be unforgettable:</h3>
<h4 style="padding-left: 40px;"> Signing several high-impact MoUs.&nbsp;</h4>
<h4 style="padding-left: 40px;">Celebrating our new China office in Hangzhou.</h4>
<h4 style="padding-left: 40px;">Showcasing breakthrough innovations.</h4>
A new chapter of collaboration begins:
Meet us at Booth E2A60 | June 24–26 | SNIEC, Shanghai.

thumbnail_Booth-post-inverBottom-image.png

Booth-post-inverBottom-image.png

Your Gateway to the Middle East & Africa

thumbnail_CPHI25_webthum_公司简介.png

CPHI25_webthum_公司简介.png

EVA Company Profile - China 2025 Digital  3.pdf

公司简介

thumbnail_CPHI25_webthum_Company-Profile.png

CPHI25_webthum_Company-Profile.png

thumbnail_CPHI25_webthum_MARC.png

CPHI25_webthum_MARC.png

Clinical Research

thumbnail_CPHI25_webthum_Product-Portfolio.png

CPHI25_webthum_Product-Portfolio.png

thumbnail_CPHI25_webthum_Limitless.png

CPHI25_webthum_Limitless.png

Limitless Naturals

EVA Pharma is a global healthcare company operating across 60+ countries, dedicated to addressing unmet patients’ needs through cutting-edge research &amp; innovation. The company boasts 2 research centers gathering first-of-its-kind capabilities to the Middle East and Africa including mRNA research and development from AI prediction to biological products.
In favor of its internationally accredited facilities and 5000+ professionals, EVA Pharma produces 1 million medicines daily, adhering to rigorous international standards.
Committed to bridging healthcare gaps globally, EVA Pharma expands its operations across the world, including Africa, particularly establishing key legal entities in Kenya and Nigeria and forging partnerships with key pharmaceutical companies. The company has a goal to enhance access to quality insulin for 30 million individuals annually living in limited-resource settings areas by 2030. Recently, it has worked to develop its vaccine- and API-manufacturing capacity, to bring essential novel healthcare technologies and products to Africa.

thumbnail_image (75).png

image (75).png

We are thrilled to announce our participation in&nbsp;one of the pharmaceutical industry's most prestigious events,&nbsp;CPHI Middle East 2024!
&nbsp;
Join us at Riyadh Front Exhibition &amp; Convention Center where EVA Pharma will showcase its dedication to advancing sustainable access to innovative healthcare solutions.
&nbsp;
Meet our team at&nbsp;booth 2B60&nbsp;and discover how EVA Pharma is bridging the globe to fulfil patients' needs with innovation, collaboration, and cutting-edge solutions.

Riyadh Front Exhibition & Convention Center, Saudi Arabia

medium_Frame 3.png

small_Frame 3.png

thumbnail_Frame 3.png

Frame 3.png

EVA Pharma at CPHI Middle East Riyadh, Saudi Arabia.
Bridging the globe to fulfil patients' needs with innovation, collaboration, and cutting-edge solutions.

CPHI Middle East 2024

EVA Pharma is a global healthcare company operating across 60+ countries, dedicated to addressing unmet patients’ needs through cutting-edge research &amp; innovation. The company boasts 2 research centers gathering first-of-its-kind capabilities to the Middle East and Africa including mRNA research and development from AI prediction to biological products.
In favor of its internationally accredited facilities and 5000+ professionals, EVA Pharma produces 1 million medicines daily, adhering to rigorous international standards.
Committed to bridging healthcare gaps globally, EVA Pharma expands its operations across the world, including Africa, particularly establishing key legal entities in Kenya and Nigeria and forging partnerships with key pharmaceutical companies. The company has a goal to enhance access to quality insulin for 30 million individuals annually living in limited-resource settings areas by 2030. Recently, it has worked to develop its vaccine- and API-manufacturing capacity, to bring essential novel healthcare technologies and products to Africa.

thumbnail_image (11).jpeg

image (11).jpeg

About EVA Pharma

We are thrilled to announce our participation in&nbsp;one of the pharmaceutical industry's most prestigious events,&nbsp;CPHI Milan 2024!
&nbsp;
Join us at&nbsp;Fiera Milano where EVA Pharma will showcase its dedication to advancing sustainable access to innovative healthcare solutions.
&nbsp;
Meet our team at&nbsp;booth 16D17&nbsp;and discover how EVA Pharma is bridging the globe to fulfil patients' needs with innovation, collaboration, and cutting-edge solutions.

medium_CPHI Italy  copy.jpg

small_CPHI Italy  copy.jpg

thumbnail_CPHI Italy  copy.jpg

CPHI Italy  copy.jpg

EVA Pharma at CPHI Milan 2024. Fiera Milano, Italy.
Bridging the globe to fulfil patients' needs with innovation, collaboration, and cutting-edge solutions.

CPHI Milan 2024

large_pexels-kaboompics-com-6335@2x.png

medium_pexels-kaboompics-com-6335@2x.png

small_pexels-kaboompics-com-6335@2x.png

thumbnail_pexels-kaboompics-com-6335@2x.png

pexels-kaboompics-com-6335@2x.png

Are you a Journalist or Media Representative and need information about us? Please feel free to get in touch with our PR Team

Media Contact 

Happening at EVA

27

Event

CPHI Worldwide 2025

27

Event

01

Event

24

Event

24

Event

Media Contact

Find out more about EVA Pharma

EVA Pharma’s roots stretch back over a hundred years.

Our experienced leadership team keeps us on track.

EVA Pharma’s success is based on its dynamic team, Our people are our power.